Highland Private Wealth Management’s Eli Lilly LLY Stock Holding History

Highland Private Wealth Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,950	Closed	-$631K	–	88
2022 Q3	$631K	Buy	1,950 +138	+8%	+$43.7K	0.1%	76
2022 Q2	$587K	Buy	1,812 +158	+10%	+$47.4K	0.09%	81
2022 Q1	$474K	Sell	1,654 -58	-3%	-$14.9K	0.06%	100
2021 Q4	$473K	Buy	1,712 +142	+9%	+$36K	0.06%	100
2021 Q3	$363K	Buy	1,570 +82	+6%	+$20.2K	0.05%	117
2021 Q2	$341K	Sell	1,488 -2	-0.1%	-$402	0.05%	118
2021 Q1	$278K	Buy	1,490 +48	+3%	+$9.39K	0.05%	122
2020 Q4	$244K	Buy	1,442 +26	+2%	+$3.88K	0.04%	131
2020 Q3	$209K	Buy	1,416 +101	+8%	+$15.6K	0.04%	125
2020 Q2	$215K	Buy	+1,315	New	+$202K	0.05%	123

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Highland Private Wealth Management's LLY Position: Q4 2022 in Review

Highland Private Wealth Management sold out of Eli Lilly (LLY) in Q4 2022, closing a stake of 1,950 shares — an estimated $631K sold.

Highland Private Wealth Management first reported a position in LLY in Q2 2020 and held it in 10 quarters. The position peaked at $631K in Q3 2022. 2,672 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

Highland Private Wealth Management reported no remaining Eli Lilly position as of Q4 2022 after selling out during the quarter.
Highland Private Wealth Management sold 1,950 Eli Lilly shares in Q4 2022, an estimated $631K.
Highland Private Wealth Management first reported a position in Eli Lilly in Q2 2020 and held it in 10 quarters.
Highland Private Wealth Management's Eli Lilly position peaked at $631K in Q3 2022.
2,672 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Highland Private Wealth Management's 13F filing for Q4 2022.